Vitamin B12 Status and Response to Vitamin B12 Supplementation in Patients With Parkinson's Disease

This study is currently recruiting participants.

Verified by Emory University, September 2006

Sponsors and Collaborators:	Emory University National Institutes of Health (NIH)
Information provided by:	Emory University
ClinicalTrials.gov Identifier:	NCT00208611

Purpose

This study examines the effects of supplementing patients who have Parkinson’s disease with Vitamin B12.

Condition	Intervention	Phase
Parkinson's Disease	Drug: Vitamin B12 Supplementation	Phase II

MedlinePlus related topics: Parkinson's Disease

Drug Information available for: Vitamin B 12 Hydroxocobalamin

Study Type:	Interventional
Study Design:	Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment

Eligibility

Ages Eligible for Study:	21 Years and older
Genders Eligible for Study:	Both

Criteria

Inclusion Criteria:

Exclusion Criteria:

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00208611

Contacts

Contact: Carol Ingram, RN	404-728-6859	cdingra@emory.edu
Contact: Marian Evatt, MD		mevatt@emory.edu

Locations

United States, Georgia
Emory University	Recruiting
Atlanta, Georgia, United States, 30329
Contact: Carol Ingram, RN 404-728-6859 cdingra@emory.edu
Contact: Marian Evatt, MD
Principal Investigator: Marian L Evatt, MD

Sponsors and Collaborators

Emory University

National Institutes of Health (NIH)

Investigators

Principal Investigator:

Marian L Evatt, MD

Emory University

More Information

Study ID Numbers:	EMORY IRB 178-2004
Study First Received:	September 13, 2005
Last Updated:	September 8, 2006
ClinicalTrials.gov Identifier:	NCT00208611
Health Authority:	United States: Institutional Review Board; United States: Federal Government

Study placed in the following topic categories:

Ganglion Cysts
Movement Disorders
Parkinson Disease
Hydroxocobalamin
Basal Ganglia Diseases

Vitamin B 12
Central Nervous System Diseases
Parkinsonian Disorders
Neurodegenerative Diseases
Brain Diseases

Additional relevant MeSH terms:

Vitamin B Complex
Hematinics
Therapeutic Uses
Growth Substances
Vitamins

Hematologic Agents
Physiological Effects of Drugs
Nervous System Diseases
Micronutrients
Pharmacologic Actions

ClinicalTrials.gov processed this record on January 16, 2009